Swiss healthcare-focused venture firm BioMedPartners has closed its second fund on CHF106m (€71.7m).
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.